Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet)

Inis Biotech LLC

Universidad Nacional De La Plata

Celina Castuma

Martin Rumbo

Erika Bartel

Maximiliano Omazabal

Griselda Moreno

Darío Flores

Eugenia Zurita

Daniela Bottero

Daniela Hozbor

María Emilia Gaillard

Agustina Errea

A vaccine for the prevention of infections with, comprising at least outer membrane vesicles (OMVs) of, excipients and/or adjuvants.may be, for example,or. The vaccine can comprise adjuvants, for example, aluminum hydroxide and other immunogens such as tetanus toxoid, diphtheria toxoid, or combinations thereof. In another preferred embodiment, the vaccine for the prevention of infections withcomprises at least outer membrane vesicles (OMVs) ofand the lipopolysaccharide of, excipients and/or adjuvants. The vaccine can comprise between 3 to 20 &#x3bc;g per dose of OMVs fromand between the amount equivalent to 10and 10bacteria per dose of lipopolysaccharide of. The adjuvant can be aluminum hydroxide and other immunogens such as tetanus toxoid, diphtheria toxoid, or combinations thereof. The Tdap vaccine exhibits cross activity.

[object Object]

Growing community of inventors

La Plata-Buenos Aires, Argentina

Celina Castuma